Takeda, Pfizer Extend Drug Co-promotion Deal, Begin Another
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Pfizer Japan agreed to extend their collaboration promoting U.S.-based Pfizer's Enbrel (etanercept) for treating rheumatoid arthritis